The manufacture 9 April 2021 Greek Vaccination Committee meets to review new data on AstraZeneca vaccine.
Intense anxiety prevails in our country regarding the Astrazeneca vaccine, with citizens especially those who have taken the first installment and have scheduled the second, to wonder if the vaccination program in Greece will change.
Greek scientists are still, however, emphasize that the benefit of vaccines outweighs the rare cases of thrombosis. Professor Sotiris Tsiodras characteristically stated the day before yesterday at an event of the Academy of Athens that the case of thrombosis when someone is seriously ill with Covid-19 is up to 69%, while the same probability after the Oxford / Astrazeneca vaccine is one in 100.000.
It is recalled that the Committee for Safety and Pharmacovigilance of the European Medicines Agency (EMA) confirmed yesterday that "unusual thrombosis with low platelets should be registered as a possible side effect". The reported cases have occurred mainly in women under 60 years.
It is noted that in Greece until Monday, according to information released by the coordinator of the "Freedom" program, Marios Themistocleous, the appointments scheduled with the Astrazeneca vaccine occupied the 25% of all scheduled appointments. As for the cancellations that had been made until Monday, for Pfizer and Moderna vaccines the rate is up to 1%, while for AstraZeneca the percentage ranges up to 3%, as Mr.. Themistocles.
EMA: Information for the general public about the AstraZeneca vaccine
- Unusual cases of low platelet blood clots have been reported in people receiving Vaxzevria (former Covid-19 Vaccine AstraZeneca).
- The probability of this happening is very low, but you should still know the symptoms, so you can get immediate medical attention to help you recover and avoid complications.
You should seek emergency medical help immediately if you have any of the following symptoms in the weeks after the injection.:
- Shortness of breath
- chest pain
- swelling in the legs
- persistent abdominal pain
- neurological symptoms, such as severe and persistent headaches or blurred vision
- tiny spots of blood under the skin beyond the injection site.
Talk to your healthcare professional or contact the relevant national health authorities if you have any questions about the availability of the vaccine in your home country..